A population-based study of the effectiveness of stereotactic ablative radiotherapy versus conventional fractionated radiotherapy for clinical stage I non-small cell lung cancer patients

Radiology and Oncology

Chih-Yen Tu^1,5¹  Te-Chun Hsia^1,6²  Hsin-Yuan Fang^2³  Ji-An Liang^3⁴  Su-Tso Yang^4,7⁵  Chia-Chin Li^3⁶  Chun-Ru Chien^3,5⁷ 

[1] Taichung, Taiwan^1;Taichung, Taiwan^2;Taichung, Taiwan^3;Taichung, Taiwan^4;Taichung, Taiwan^5;Taichung, Taiwan^6;Taichung, Taiwan^7

关键词: stereotactic ablative radiotherapy;    conventional fractionated radiotherapy;    non-small cell lung cancer;   

DOI  :  10.1515/raon-2017-0058

学科分类：肿瘤学

来源: Onkoloski Institut Ljubljana / Institute of Oncology Ljubljana

【 摘 要 】

BackgroundStereotactic ablative radiotherapy (SABR) is a promising option for non-operated early-stage non-small cell lung cancer (NSCLC) compared to conventional fractionated radiotherapy (CFRT). However, results from conclusive randomized controlled trials are not yet available. The aim of our study was to explore the effectiveness of SABR vs. CFRT for non-operated early-stage NSCLC.

【 授权许可】

Unknown